Global Blood Therapeutics

+$0.69 (+2.71%) Today
+$0.20 (+0.76%) As of 9:14 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GBT and other ETFs, options, and stocks.

About GBT

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases.

CEO
Ted W. Love
Employees
457
Headquarters
South San Francisco, California
Founded
2011

GBT Key Statistics

Market cap
1.70B
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.15M
High today
$26.42
Low today
$24.33
Open price
$25.47
Volume
1.56M
52 Week high
$41.73
52 Week low
$22.67

GBT Earnings

-$1.36
-$0.91
-$0.45
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 2, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure